SEC Form 4 · accession 0000899243-17-001453
LANXESS Solutions US Inc. · CHMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan M Swiech
Officer — See Remarks
Period of report
Jan 13, 2017
Accepted (ET)
Jan 18, 2017 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091862
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 13, 2017 | M | 20,928 | — | A | 101,447 | D | |
| Common Stock | Jan 13, 2017 | F | 6,565 | $33.15 | D | 94,882 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance SharesF1 | — | Jan 13, 2017 | M | 14,141 | D | — | Mar 1, 2017 | Common Stock | 20,928 | 0 | D |
Explanation of responses
- F1Each performance share was granted in 2014 and represented a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock based on Chemtura Corporation's total shareholder return against the companies comprising the Dow Jones US Chemical Index (the "TSR Metric"). 14,141 shares of common stock represented the target amount of the award granted in 2014. The performance shares vested at 148% of the target amount based on the TSR Metric, for a total payout of 20,928 shares of common stock.
Remarks
EVP, Organometallics Specialties & Support Services